OTCPK:PKTX (USA)

ProtoKinetix Inc

$ 0.1 -0.01 (-10.91%)
Volume: 174,871 Avg Vol (1m): 133,911
Market Cap $: 26.45 Mil Enterprise Value $: 26.43 Mil
P/E (TTM): 0.00 P/B: 100.00
Earnings Power Value 0
Net Current Asset Value 0
Tangible Book 0
Projected FCF -0.02
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked lower than
100.00% of 1078 companies
in the Biotechnology industry.
Industry Max: 20856.43, Med: 64.02, Min: 0.01
PKTX: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.74, Max: 10000
Current: 10000
0.01
10000
Interest Coverage No Debt
Interest Coverage ranked lower than
100.00% of 500 companies
in the Biotechnology industry.
Industry Max: 22756408, Med: 10000, Min: 0.12
PKTX: No Debt
Ranked among companies with meaningful Interest Coverage only.
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 50.88
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC -751.74%
WACC 21.51%

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
ROE % -420.57
ROE ranked lower than
100.00% of 989 companies
in the Biotechnology industry.
Industry Max: 326.78, Med: -42.82, Min: -100794.12
PKTX: -420.57
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -420.57, Med: -347.65, Max: -338.51
Current: -420.57
-420.57
-338.51
ROA % -379.11
ROA ranked lower than
100.00% of 1084 companies
in the Biotechnology industry.
Industry Max: 224.74, Med: -34.77, Min: -3751.92
PKTX: -379.11
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -2721.21, Med: -693.6, Max: -285.66
Current: -379.11
-2721.21
-285.66
ROC (Joel Greenblatt) % -4281.46
ROC (Joel Greenblatt) ranked lower than
100.00% of 1036 companies
in the Biotechnology industry.
Industry Max: 641137.84, Med: -521.46, Min: -3427023.81
PKTX: -4281.46
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -12200, Med: -5040, Max: -862.28
Current: -4281.46
-12200
-862.28
3-Year Total EBITDA Growth Rate 1.00
3-Year EBITDA Growth Rate ranked lower than
100.00% of 802 companies
in the Biotechnology industry.
Industry Max: 1406.7, Med: 4.6, Min: -2038.5
PKTX: 5.9
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 20.8, Max: 63.2
Current: 5.9
0
63.2
3-Year EPS w/o NRI Growth Rate 5.90
3-Year EPS w/o NRI Growth Rate ranked lower than
100.00% of 763 companies
in the Biotechnology industry.
Industry Max: 1406.7, Med: 5.7, Min: -2103.4
PKTX: 5.9
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 8.25, Max: 53.6
Current: 5.9
0
53.6

» PKTX's 30-Y Financials

Financials (Next Earnings Date: )

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with OTCPK:PKTX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325411    SIC : 2834
Compare GREY:VBIO OTCPK:CRYO TSE:6190 TSXV:CZO NAS:TTNP OSTO:XINT XBRA:1BSL01AE NAS:SLS ASX:ZLD XSAT:SPAG ASX:EX1 BOM:540679 NAS:LIFE NAS:CTXR NAS:ONTX AMEX:RNN XCNQ:MMJ NZSE:BLT OSTO:PROMO ROCO:4732
Traded in other countries
Address 412 Mulberry Street, Marietta, OH, USA, 45750
ProtoKinetix Inc is a US-based research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage and transplanting cells, tissues and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen cyanide.

Ratios

Current vs industry vs history
PB Ratio 100.00
PB Ratio ranked lower than
100.00% of 962 companies
in the Biotechnology industry.
Industry Max: 2236, Med: 4.1, Min: 0.05
PKTX: 100
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0, Med: 0, Max: 180
Current: 100
0
180
EV-to-EBIT -19.67
EV-to-EBIT ranked lower than
100.00% of 261 companies
in the Biotechnology industry.
Industry Max: 4391.42, Med: 22.17, Min: 0.02
PKTX: -19.67
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -34.01, Med: 0, Max: 0
Current: -19.67
-34.01
0
EV-to-EBITDA -19.69
EV-to-EBITDA ranked lower than
100.00% of 281 companies
in the Biotechnology industry.
Industry Max: 28816.43, Med: 18.08, Min: 0.02
PKTX: -19.69
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -34.05, Med: 0, Max: 0
Current: -19.69
-34.05
0
Current Ratio 0.65
Current Ratio ranked lower than
100.00% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.46, Min: 0.01
PKTX: 0.65
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.01, Med: 0.6, Max: 76.2
Current: 0.65
0.01
76.2
Quick Ratio 0.65
Quick Ratio ranked lower than
100.00% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.18, Min: 0.01
PKTX: 0.65
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.01, Med: 0.6, Max: 76.2
Current: 0.65
0.01
76.2

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -5.80
3-Year Share Buyback Rate ranked lower than
100.00% of 857 companies
in the Biotechnology industry.
Industry Max: 43.5, Med: -13.4, Min: -1815.4
PKTX: -5.8
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -70.5, Med: -17.95, Max: 57.7
Current: -5.8
-70.5
57.7

Valuation & Return

Current vs industry vs history
Earnings Yield (Joel Greenblatt) % -5.09
Earnings Yield (Greenblatt) ranked lower than
100.00% of 1081 companies
in the Biotechnology industry.
Industry Max: 5000, Med: -7.73, Min: -10000
PKTX: -5.09
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -19.47, Med: 0, Max: 0
Current: -5.09
-19.47
0

More Statistics

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 2
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N